OPEC+ set to keep oil output targets steady, sources say Reuters
Why AMRX Stock advanced +0.99% Today — RQD Quant Desk Flash
Amneal Pharmaceuticals Inc. (AMRX) receives a Roarable Rating of D+ (Sell) and flashes a Red SELL / AVOID warning (65/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (+146.4% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.
Why AMRX Stock advanced +0.99% Today — RQD Quant Desk Flash
Amneal Pharmaceuticals Inc. (AMRX) advanced +0.99% to $21.35 as options desks priced 57% call premium vs. 43% put protection around the $21 max-pain magnet. Accounting Warning: Paper earnings outpaced operating cash flow (+146.4% (NI vs OCF)) as receivables rose.
- ▸Technical Tape: Trading at 97% of its 52-week range ($10.68 – $21.68) with RSI-14 at 67.7 (BULLISH MOMENTUM).
- ▸Whale Options Positioning: $2.6M in bullish call flow vs. $1.9M in put flow (Put/Call 0.75x, implied earnings swing ±7.2%).
- ▸Primary SEC / Cross-Feed Trigger: AMRX Accounting Gap: Net Income (+161.6%) Outpaced OCF (+15.2%) With +2.2% Working-Capital Build
Germany must do more to boost gas reserves as storage levels hit record low, lobby group says Reuters
Iranian envoys meet Qatari mediators as threat looms of US strikes after midterms Reuters
UN says Yemeni staff member dies in Houthi custody, demands investigation Reuters
The Colossus data centers and a power plant that SpaceXAI is also building in Southaven, Mississippi, have faced community backlash for years.
Borsa Istanbul general manager detained in fund investigation, Anadolu Agency says Reuters
The Binance hack of $6.3 billion, the largest crypto theft ever, is a wake-up call for investors to understand how coin is guarded and the risk of losing it.
Legal recruiter Danielle Thompson shares her best advice for the employees of Weil, Gotshal & Manges and others who face a company wind-down or dissolution.
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring AMRX)
- ✓Live walkthrough of AMRX's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
AMRX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +8.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on AMRX today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for AMRX. Explore sector supply chains on /butterfly.
AMRX Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is AMRX stock moving today?
Why AMRX Stock advanced +0.99% Today — RQD Quant Desk Flash. Accounting Warning: Paper earnings outpaced operating cash flow (+146.4% (NI vs OCF)) as receivables rose.